Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies
Clinical trial NCT06699771 · RECRUITING
Trial details
- NCT number
- NCT06699771
- Sponsor
- GC Cell Corporation
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-07
- Primary completion
- 2027-08-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.